New Anticancer Theobromine Derivative Targeting EGFR<sup>WT</sup> and EGFR<sup>T790M</sup>: Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies.

导出 OA

翻译打印收藏纠错

作者： Eslam B,Elkaeed ^[1] ; Reda G,Yousef ^[2] ; Hazem,Elkady ^[2] ; Aisha A,Alsfouk ^[3] ; Dalal Z,Husein ^[4] ; Ibrahim M,Ibrahim ^[5] ; Ahmed M,Metwaly ^[6] ; Ibrahim H,Eissa ^[7]

作者单位： Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh 13713, Saudi Arabia. ^[1] Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt. ^[2] Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia. ^[3] Chemistry Department, Faculty of Science, New Valley University, El-Kharja 72511, Egypt. ^[4] Biophysics Department, Faculty of Science, Cairo University, Cairo 12613, Egypt. ^[5] Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt. ^[6] Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria 21934, Egypt. ^[7]

关键词 DFT EGFR MD simulations Molecular docking anticancer semi-synthesis theobromine derivative